• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模仿HIV-1 gp120中除V3环以外的特定二硫键环的肽不会引发病毒中和抗体。

Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.

作者信息

Neurath A R, Strick N, Fields R, Jiang S

机构信息

Lindsley F. Kimball Research Institute, New York Blood Center, New York 10021.

出版信息

AIDS Res Hum Retroviruses. 1991 Aug;7(8):657-62. doi: 10.1089/aid.1991.7.657.

DOI:10.1089/aid.1991.7.657
PMID:1718344
Abstract

The positions of all 9 intrachain disulfide bonds within the envelope glycoprotein gp120 of the human immunodeficiency virus (HIV-1) have been established recently. Peptides expected to mimic some of the disulfide-bonded domains [(120-133)-(203-221); (133-138)-(164-203); (224-254); (391-425) and (385-392)-(425-452)] were synthesized. All peptides, except (120-133)-(203-221), elicited in immunized rabbits relatively high levels of antibodies reacting with gp120 in enzyme-linked immunosorbent assay (ELISA) and/or Western immunoblot assays. However, these antibodies failed to neutralize the infectivity of HIV-1. Combined with earlier reports concerning other gp120 loop peptides, these results confirm the uniqueness of the V3 (303-338) loop in encompassing a principal determinant(s) involved in virus neutralization.

摘要

人类免疫缺陷病毒(HIV-1)包膜糖蛋白gp120内所有9个链内二硫键的位置最近已确定。合成了预期模拟某些二硫键结合结构域[(120 - 133)-(203 - 221);(133 - 138)-(164 - 203);(224 - 254);(391 - 425)和(385 - 392)-(425 - 452)]的肽。除了(120 - 133)-(203 - 221)之外,所有肽在免疫的兔子中均引发了相对高水平的抗体,这些抗体在酶联免疫吸附测定(ELISA)和/或Western免疫印迹测定中与gp120发生反应。然而,这些抗体未能中和HIV-1的感染性。结合有关其他gp120环肽的早期报告,这些结果证实了V3(303 - 338)环在包含参与病毒中和的主要决定簇方面的独特性。

相似文献

1
Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.模仿HIV-1 gp120中除V3环以外的特定二硫键环的肽不会引发病毒中和抗体。
AIDS Res Hum Retroviruses. 1991 Aug;7(8):657-62. doi: 10.1089/aid.1991.7.657.
2
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.能够呈现HIV-1 V3环冠部且构象适合产生447-52D样抗体的免疫原的设计。
Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588.
3
Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.用与HIV-1包膜糖蛋白全长V3高变环对应的合成肽免疫的黑猩猩的抗体反应。
AIDS Res Hum Retroviruses. 1991 Oct;7(10):813-23. doi: 10.1089/aid.1991.7.813.
4
Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.一种单克隆抗独特型抗体对HIV-1中和单克隆抗体110.3和110.4以及gp120的V3环的双重特异性。
Virology. 1994 Dec;205(2):554-7. doi: 10.1006/viro.1994.1678.
5
Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies.可变环缺失的1型人类免疫缺陷病毒包膜糖蛋白的免疫原性及引发中和抗体的能力。
Virology. 2003 Jan 5;305(1):124-37. doi: 10.1006/viro.2002.1727.
6
Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.V3特异性抗体在涉及1型人类免疫缺陷病毒原始毒株和实验室适应毒株的中和试验中的不同作用。
AIDS Res Hum Retroviruses. 1995 Nov;11(11):1379-91. doi: 10.1089/aid.1995.11.1379.
7
Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.HIV-1包膜多表位多肽诱导针对V3环的中和单克隆抗体。
AIDS Res Hum Retroviruses. 1994 Mar;10(3):235-43. doi: 10.1089/aid.1994.10.235.
8
Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.利用二维核磁共振差异光谱法研究1型人类免疫缺陷病毒主要中和决定簇与抗gp120病毒中和抗体复合物的构象。
Biochemistry. 1997 Jul 15;36(28):8619-27. doi: 10.1021/bi970520f.
9
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity.检测来自人类免疫缺陷病毒1型(HIV-1)感染个体的血清,以寻找与对应HIV-1 gp120主要中和决定簇的肽发生反应的抗体,并检测其体外中和活性。
J Virol. 1992 Sep;66(9):5210-5. doi: 10.1128/JVI.66.9.5210-5215.1992.
10
Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope.针对人类免疫缺陷病毒1型外膜糖蛋白第二个可变区产生的抗血清具有交叉中和作用,并且当它们与针对V3中和表位的抗血清共同作用时,中和指数会增加。
J Gen Virol. 1993 Dec;74 ( Pt 12):2609-17. doi: 10.1099/0022-1317-74-12-2609.

引用本文的文献

1
Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.针对包膜糖蛋白gp120/gp41来源肽段的抗血清增强1型人类免疫缺陷病毒感染
J Exp Med. 1991 Dec 1;174(6):1557-63. doi: 10.1084/jem.174.6.1557.
2
Cellular and humoral antigenic epitopes in HIV and SIV.HIV和SIV中的细胞和体液抗原表位
Immunology. 1992 Aug;76(4):515-34.